Development

Articles

To best carry out the vision of Hatch-Waxman, Congress must act now on biogenerics.

Consumers Need Access to Lower-Cost Biogenerics

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Contract manufacturers report improving business conditions, but will they continue?

Uptick or Sustainable Growth?

Analysis of the opportunities and challenges in the biosimilars market.

Opportunities in the Biosimilars Market

From last-minute product inserts to putting out fires, close calls are a common occurrence.

Quick Saves and Near Misses

Michelle Hoffman, editorial director of Pharmaceutical Technology.

If both sides of the aisle don't agree on even mild healthcare reform soon, the bill could die out.

Skinny or Dead

The second annual Pharmaceutical Technology Bioprocessing Survey offers a snapshot of the industry following 2009's megamergers.

Trends in Bioprocessing

Merck To Eliminate 15,000 jobs; Tauzin Stepping Down At PhRMA; And More.

Week Of Feb. 22, 2010: Company And People Notes: Merck To Eliminate 15,000 Jobs; Tauzin Stepping Down At PhRMA; And More.

RUSNANO, a corporation established by the Russian government to foster the development of nanotechnology, launched a project last week to manufacture targeted-delivery nanodrugs to treat malignant neoplasms.

Russian Groups Agree to Produce Anticancer Nanodrugs

The Society for Chemical Manufacturers and Affiliates offered its support for a Senate proposal to extend to 2015 current chemical-security standards, the Chemical Facility Anti-Terrorism Standards, which are set to expire this year.

SOCMA Lends Support for Senate Chemical Security Bill

Abbott Completes Acquisition Of Solvay; Merck Names President of Consumer Healthcare; And More.

Ingredients